Samsung SDS will conduct a series of airplane pilot projects in November to exam blockchain-powered medicine distribution management. The goal of these tests is to guarantee transparency in the process of tracking pharmaceutical drugs.

Co-ordinate to Yankup, the It branch of Samsung Group announced the pilot programs, named "Confusing innovation applied science for tracking drug distribution history," at the BioPharma Cold Chain Logistics session in Seoul, South Korea.

Officials from Samsung SDS also said that they've received "several" participation applications for the pilots from unnamed pharmaceutical firms, distributors, and even medical institutions in Southward Korea.

Lee Eun-young, senior researcher at Samsung SDS, stated that the pilots volition last between three and 6 months, commenting:

"Through the drug distribution history management service, information technology is possible to comply with regulations and innovate business by implementing product-specific history direction, real-fourth dimension distribution history tracking, and automatic reporting functions."

During the announcement, Samsung's IT branch said that the pilots would consist of an IoT-linked temperature history tracking service, which will be implemented along with automated history management for incoming and approachable goods. This has been chosen "to minimize handwritten input," verify returns, and collections with the support of a secure database.

If successful, these pilots will be commercialized after passing domestic and foreign regulatory compliance in June of side by side yr. Lee told local media:

"The value of blockchain in the healthcare industry is expected to grow from $176.80 million in 2018 to $v.61 billion in 2025, and past 2025, 55% of healthcare solutions are expected to adopt blockchain for commercial purposes."

Daegu, the quaternary-largest city in South Korea, recently announced its plans to classify over $6 million towards blockchain and bogus intelligence pedagogy.